Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs

OBJECTIVE: To comprehensively assess the pharmacogenomic evidence of routinely-used drugs for clinical utility. METHODS: From January 2, 2011 to May 31, 2013, we assessed 71 drugs by identifying all drug/genetic variant combinations with published clinical pharmacogenomic evidence. Literature suppor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mayo Clin Proc
Auteurs principaux: Kaufman, Amy L., Spitz, Jared, Jacobs, Michael, Sorrentino, Matthew, Yuen, Shennin, Danahey, Keith, Saner, Donald, Klein, Teri E., Altman, Russ B., Ratain, Mark J., O’Donnell, Peter H.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475352/
https://ncbi.nlm.nih.gov/pubmed/26046407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2015.03.016
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires